Diverse Populations,
Accelerating Oncology Innovation.
Empowering oncology practices to become high-performing clinical trial centers
An End-to-End Solution is Required to Address the Multitude of Challenges
Only 5% of patients are enrolled in clinical trials
There is lack of diversity in clinical research
Because the number of drugs in development is expanding exponentially, access to clinical trials needs to expand as well
Oncologists and oncology practices are overburdened with administrative work and lack time to engage in clinical research
Expensive infrastructure and resources limit the adoption of clinical trials at community oncology centers
Routine-care data is not standardized and is difficult to use for clinical research, it is challenging to determine which patients are eligible for clinical trials
Drug development takes too long. It can take 10 years for a drug to make its way through to the patients who need it